食管癌新辅助放化疗现有问题探讨

Discussion on current problems of neoadjuvant chemoradiotherapy for esophageal carcinoma

新辅助放化疗是局部晚期可手术食管癌多家指南推荐的首选治疗模式,但仍有一些问题需要进一步探讨。本文就目前困扰临床的多个问题进行了梳理,期望能为今后的食管癌新辅助放化疗的顺利进行提供建设性建议。

Neoadjuvant chemoradiotherapy is the preferred treatment mode for the diagnosis and treatment of locally advanced operable esophageal carcinoma recommended by many guidelines.However,some problems remain to be further explored.In this article,current problems perplexing clinical practice were sorted out,aiming to provide constructive suggestions for the smooth development of neoadjuvant chemoradiotherapy for esophageal carcinoma in the future.